Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T10:45:20.175Z Has data issue: false hasContentIssue false
  • English
  • Français

Number of embryos biopsied as a predictive indicator for the outcome of preimplantation genetic diagnosis by fluorescence in situ hybridisation in translocation cases

Published online by Cambridge University Press:  20 January 2015

P. Tulay ,
M. Gultomruk ,
N. Findikli  and
M. Bahceci
P. Tulay*
Affiliation:
Near East University, Faculty of Medicine, Medical Genetics, East Avenue, PO Box: 922022 Yakin Dogu Bulvari, Nicosia, Cyprus. Bahceci Fulya Assisted Reproductive Technology Centre, Hakkı Yeten St., 11/3, 34365 Istanbul, Turkey.
M. Gultomruk
Affiliation:
Bahceci Fulya Assisted Reproductive Technology Centre, Hakkı Yeten St., 11/3, 34365 Istanbul, Turkey.
N. Findikli
Affiliation:
Bahceci Fulya Assisted Reproductive Technology Centre, Hakkı Yeten St., 11/3, 34365 Istanbul, Turkey.
M. Bahceci
Affiliation:
Bahceci Fulya Assisted Reproductive Technology Centre, Hakkı Yeten St., 11/3, 34365 Istanbul, Turkey.
*
All correspondence to: Pinar Tulay. Near East University, Faculty of Medicine, Medical Genetics, East Avenue, PO Box: 922022 Yakin Dogu Bulvari, Nicosia, Cyprus. Tel: +90 392 444 0938. Fax: +90 212 310 3190. e-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

This study aimed to investigate the optimum number of embryos to be biopsied in order to increase the likelihood of obtaining a balanced/normal embryo following preimplantation genetic diagnosis (PGD) by fluorescence in situ hybridisation (FISH) for translocation carriers. Patients with low number of fertilised oocytes (≤5) or low number of embryos available for PGD (<7) underwent multiple hormonal stimulation cycles and their embryos from each cycle were vitrified and accumulated to obtain at least three embryos for PGD. Fifty-seven PGD cycles were performed for translocation carriers by FISH on day 3 of embryo development. PGD and pregnancy outcomes were examined according to the number of embryos biopsied. The cancellation rates of embryo transfer for the reciprocal translocation carriers were 40% when more than eight embryos were biopsied and it was as high as 78% when low number of embryos (less than nine) were biopsied. For Robertsonian translocation carriers, when more than eight embryos were biopsied, there were no embryo transfer cancellations. This study showed that when there are more than nine embryos biopsied for PGD, the likelihood of obtaining a balanced embryo and positive pregnancy outcome is significantly higher (P < 0.05) in such the overall pregnancy rate was 63% for reciprocal and 86% for Robertsonian carriers. This was reduced to only 7% for reciprocal and 14% for Robertsonian translocation carriers when less than nine embryos were biopsied. One of the limitations of this study was that the analysis was performed by FISH and more studies should investigate the outcomes of embryo accumulation following comprehensive chromosome analysis.

Keywords

Biopsied embryo for PGDEmbryo accumulationHuman embryoPreimplantation genetic diagnosisTranslocation
Type
Research Article
Information
Zygote , Volume 24 , Issue 1 , February 2016 , pp. 107 - 114
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chi, F., Luo, C., Yin, P., Hong, L., Ruan, J., Huang, M., Duan, T. & Tong, G. (2013). Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison with vitrification of day 2 cleavage-stage embryos. Zygote 1–8; doi:10.1017/S0967199413000373 [Epub ahead of print]CrossRefGoogle Scholar
Chung, J.T., Son, W.Y., Zhang, X.Y., Ao, A., Tan, S.L. & Holzer, H. (2012). Normal birth following PGD for reciprocal translocation after serial vitrification of oocytes from a poor responder: a case report. Reprod. Biomed. Online 25, 521–6.Google Scholar
Cobo, A., Garrido, N., Crespo, J., Jose, R. & Pellicer, A. (2012). Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod. Biomed. Online 24, 424–32.Google Scholar
Ford, C.E. & Clegg, H.M. (1969). Reciprocal translocations. Br. Med. Bull. 25, 110–4.Google Scholar
Harper, J.C., Wilton, L., Traeger-Synodinos, J., Goossens, V., Moutou, C., Sengupta, S.B., Pehlivan Budak, T., Renwick, P., De Rycke, M., Geraedts, J.P. & Harton, G. (2012). The ESHRE PGD Consortium: 10 years of data collection. Hum. Reprod. Update 18, 234–47.Google Scholar
Jacobs, P.A., Melville, M., Ratcliffe, S., Keay, A.J. & Syme, J. (1974). A cytogenetic survey of 11,680 newborn infants. Ann. Hum. Genet. 37, 359–76.Google Scholar
Liu, S.Y., Teng, B., Fu, J., Li, X., Zheng, Y. & Sun, X.X. (2013). Obstetric and neonatal outcomes after transfer of vitrified early cleavage embryos. Hum. Reprod. 28, 2093–100.CrossRefGoogle ScholarPubMed
Moutou, C., Goossens, V., Coonen, E., De Rycke, M., Kokkali, G., Renwick, P., Sengupta, S. B., Vesela, K. & Traeger-Synodinos, J. (2014). ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010. Hum. Reprod. 29, 880–903.Google Scholar
Scriven, P.N., Flinter, F.A., Khalaf, Y., Lashwood, A. & Mackie Ogilvie, C. (2013). Benefits and drawbacks of preimplantation genetic diagnosis (PGD) for reciprocal translocations: lessons from a prospective cohort study. Eur. J. Hum. Genet. 21, 1035–41.Google Scholar
Simopoulou, M., Harper, J.C., Fragouli, E., Mantzouratou, A., Speyer, B.E., Serhal, P., Ranieri, D.M., Doshi, A., Henderson, J., Rodeck, C.H. & Delhanty, J.D. (2003). Preimplantation genetic diagnosis of chromosome abnormalities: implications from the outcome for couples with chromosomal rearrangements. Prenat. Diagn. 23, 652–62.Google Scholar
Ulug, U., Turan, E., Tosun, S.B., Erden, H.F. & Bahceci, M. (2007). Comparison of preovulatory follicular concentrations of epidermal growth factor, insulin-like growth factor-I, and inhibins A and B in women undergoing assisted conception treatment with gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists. Fertil. Steril. 87, 995–8.Google Scholar
Van Landuyt, L., Van De Velde, H., De Vos, A., Haentjens, P., Blockeel, C., Tournaye, H. & Verheyen, G. (2013). Influence of cell loss after vitrification or slow-freezing on further in vitro development and implantation of human day 3 embryos. Hum. Reprod. 28, 2943–9.Google Scholar